Free Trial
→ 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (From WealthPress) (Ad) Free MOR Stock Alerts

MorphoSys (MOR) SEC Filings & 10K Form

MorphoSys logo
$18.96 0.00 (0.00%)
(As of 12/20/2024 ET)
Compare

Recent MorphoSys SEC Filings

Export to Excel
DateFilerForm TypeView
10/17/2024
3:54 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 15-12G
10/04/2024
3:21 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:24 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:27 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:30 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:33 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:36 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:18 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:16 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form POSASR
08/27/2024
9:14 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
08/13/2024
3:31 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/07/2024
3:51 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
08/07/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/05/2024
7:14 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/01/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/31/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/30/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/29/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/25/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/25/2024
3:05 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
07/18/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/18/2024
10:25 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
3:20 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/05/2024
5:48 AM		MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9
07/05/2024
5:02 AM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
07/02/2024
9:18 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/21/2024
9:07 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
3:41 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
3:33 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
06/20/2024
2:38 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-C
06/17/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/10/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/10/2024
11:06 AM		GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G/A
06/10/2024
10:01 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
3:36 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2024
9:22 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
06/04/2024
9:17 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2024
9:17 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
9:17 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
9:16 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
9:13 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
1:19 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/23/2024
9:11 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
8:04 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
9:07 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2024
9:15 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
3:43 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/16/2024
3:31 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/16/2024
9:11 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
9:27 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2024
9:19 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2024
9:31 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2024
9:08 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
3:45 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/07/2024
9:24 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/06/2024
9:07 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2024
9:29 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
3:31 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/02/2024
9:43 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
9:07 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:57 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
3:15 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
9:17 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
9:11 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/25/2024
9:38 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
10:03 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
9:14 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
9:32 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
9:17 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
3:31 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D
04/18/2024
9:13 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
3:49 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
04/17/2024
3:30 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
9:12 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
2:44 PM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/12/2024
9:54 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
10:57 AM		MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9
04/11/2024
5:01 AM		MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
04/09/2024
9:07 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
9:19 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
9:15 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
04/02/2024
9:08 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
12:16 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2024
10:15 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
10:37 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
10:17 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
5:47 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2024
10:27 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
3:12 PM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
10:13 AM		MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:MOR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
Top Picks for Trump’s Pro-Crypto America
Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...
Crypto 101 Media | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored